نتایج جستجو برای: methylphenidate mph

تعداد نتایج: 6344  

Journal: :Cerebral cortex 2014
Scott J Moeller Jean Honorio Dardo Tomasi Muhammad A Parvaz Patricia A Woicik Nora D Volkow Rita Z Goldstein

Previous studies have suggested dopamine to be involved in error monitoring/processing, possibly through impact on reinforcement learning. The current study tested whether methylphenidate (MPH), an indirect dopamine agonist, modulates brain and behavioral responses to error, and whether such modulation is more pronounced in cocaine-addicted individuals, in whom dopamine neurotransmission is dis...

Journal: :Journal of child and adolescent psychopharmacology 2003
Michael G Aman Brett Buican L Eugene Arnold

OBJECTIVE To determine response of low-IQ children with attention deficit hyperactivity disorder (ADHD) symptoms to methylphenidate (MPH). METHODS An aggregated analysis was conducted in 90 children with low IQ who received the same dose regimen of MPH in three independent, placebo-controlled studies. Active drug and placebo were given from 2 to 4 weeks each. Outcome measures included teacher...

Journal: :Applied neuropsychology. Adult 2017
Anselm B M Fuermaier Lara Tucha Janneke Koerts Matthias Weisbrod Klaus W Lange Steffen Aschenbrenner Oliver Tucha

Neuropsychological research on adults with attention deficit hyperactivity disorder (ADHD) revealed considerable impairments in memory functions related to executive control. However, only limited evidence exists supporting the effects of pharmacological treatment using methylphenidate (MPH) on memory functions. The aim of the present study was, therefore, to explore the impact of MPH on variou...

Journal: :Journal of child and adolescent psychopharmacology 2007
Howard B Abikoff Benedetto Vitiello Mark A Riddle Charles Cunningham Laurence L Greenhill James M Swanson Shirley Z Chuang Mark Davies Elizabeth Kastelic Sharon B Wigal Lori Evans Jaswinder K Ghuman Scott H Kollins James T McCracken James J McGough Desiree W Murray Kelly Posner Anne M Skrobala Tim Wigal

OBJECTIVE The purpose of this study was to examine the effects of methylphenidate (MPH) on functional outcomes, including children's social skills, classroom behavior, emotional status, and parenting stress, during the 4-week, double-blind placebo controlled phase of the Preschoolers with Attention Deficit/Hyperactivity Disorder (ADHD) Treatment Study (PATS). METHODS A total of 114 preschoole...

Journal: :Human psychopharmacology 2016
Jeong Ha Park Young Sik Lee Ji Hyun Sohn Doug Hyun Han

OBJECTIVE There is a high prevalence of problematic online gaming in adolescents with attention deficit hyperactivity disorder (ADHD). In the current study, we compared the effectiveness of atomoxetine (ATM) and methylphenidate (MPH) on problematic online gaming in adolescents with ADHD. METHODS We recruited 86 adolescents diagnosed with ADHD together with Internet gaming disorder. These part...

2017
Michael Huss Praveen Duhan Preetam Gandhi Chien-Wei Chen Carsten Spannhuth Vinod Kumar

Attention-deficit/hyperactivity disorder (ADHD) is a chronic psychiatric disorder characterized by hyperactivity and/or inattention and is often associated with a substantial impact on psychosocial functioning. Methylphenidate (MPH), a central nervous system stimulant, is commonly used for pharmacological treatment of adults and children with ADHD. Current practice guidelines recommend optimizi...

2014
Marco A Bottelier Marieke LJ Schouw Anne Klomp Hyke GH Tamminga Anouk GM Schrantee Cheima Bouziane Michiel B de Ruiter Frits Boer Henricus G Ruhé Damiaan Denys Roselyne Rijsman Ramon JL Lindauer Hans B Reitsma Hilde M Geurts Liesbeth Reneman

BACKGROUND Animal studies have shown that methylphenidate (MPH) and fluoxetine (FLX) have different effects on dopaminergic and serotonergic system in the developing brain compared to the developed brain. The effects of Psychotropic drugs On the Developing brain (ePOD) study is a combination of different approaches to determine whether there are related findings in humans. METHODS/DESIGN Anim...

2017
Yoko Nakanishi Toyosaku Ota Junzo Iida Kazuhiko Yamamuro Naoko Kishimoto Kosuke Okazaki Toshifumi Kishimoto

BACKGROUND The stimulant methylphenidate (MPH) and the nonstimulant atomoxetine (ATX) are the most commonly-prescribed pharmacological treatments for attention deficit/hyperactivity disorder (ADHD). However, the drug-specific mechanism of action on brain function in ADHD patients is not well known. This study examined differences in prefrontal hemodynamic activity between MPH and ATX in childre...

Journal: :Physiology & Behavior 2016
Bruno Garcia Montagnini Kennia Moura Silveira Bruna Caroline Pierone Nathália de Azevedo Camim Janete Aparecida Anselmo-Franci Suzana de Fátima Paccola Mesquita Ana Carolina Inhasz Kiss Daniela Cristina Ceccatto Gerardin

Methylphenidate (MPH), a psychoactive agent that acts mainly by blocking the uptake of dopamine, is the main drug used to treat Attention Deficit Hyperactivity Disorder in children and adolescents. During development, important changes in brain architecture and plasticity occur, these changes, sensitive to exposure to stimulant drugs, are important in the control of GnRH secretion, influencing ...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2014
Ina Schabram Karsten Henkel Siamak Mohammadkhani Shali Claudia Dietrich Jörn Schmaljohann Oliver Winz Susanne Prinz Lena Rademacher Bernd Neumaier Marc Felzen Yoshitaka Kumakura Paul Cumming Felix M Mottaghy Gerhard Gründer Ingo Vernaleken

Methylphenidate (MPH) inhibits the reuptake of dopamine and noradrenaline. PET studies with MPH challenge show increased competition at postsynaptic D2/3-receptors, thus indirectly revealing presynaptic dopamine release. We used [(18)F]fluorodopamine ([(18)F]FDOPA)-PET in conjunction with the inlet-outlet model (IOM) of Kumakura et al. (2007) to investigate acute and long-term changes in dopami...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید